The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 2, 2003, Pages 787-792

  Misra, Madhusmita ^a   MacLaughlin, David T ^a   Donahoe, Patricia K ^a   Lee, Mary M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUELLERIAN INHIBITING FACTOR; SEX HORMONE;

ADOLESCENT; ARTICLE; CHILD; CRYPTORCHISM; EVALUATION; FEMALE; GONADAL DYSGENESIS; HERMAPHRODITISM; HUMAN; MAJOR CLINICAL STUDY; OVARY TUMOR; PHENOTYPE; PRIORITY JOURNAL; TESTIS; VIRILIZATION;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CLITORIS; FEMALE; GLYCOPROTEINS; GONADAL DYSGENESIS; GROWTH INHIBITORS; HUMANS; INFANT; INFANT, NEWBORN; KARYOTYPING; PHENOTYPE; SEVERITY OF ILLNESS INDEX; TESTICULAR HORMONES; VIRILISM;

EID: 0037328571     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020889     Document Type: Article

References (42)

1. Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, Wilson C, Imbeaud S, Pepinsky RB, Guerrier D, Boussin L 1993 Anti-mullerian hormone: the Jost factor. Recent Prog Horm Res 48:1-59
2. Racine C, Rey R, Forest MG, Louis F, Ferre A, Huhtaniemi I, Josso N, di Clemente N 1998 Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95:594-599
3. Lee MM, Seah CC, Masiakos PT, Sottas CM, Preffer FI, Donahoe PK, MacLaughlin DT, Hardy MP 1999 Mullerian inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology 140:2819-2827
4. McGee EA, Smith R, Spears N, Nachtigal MW, Ingraham H, Hsueh AJ 2001 Mullerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol Reprod 64:293-298
5. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899
6. Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, Lee MM 2001 Mullerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl 22:750-758
7. Ikeda Y, Nagai A, Ikeda MA, Hayashi S 2002 Increased expression of Mullerian inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate. Endocrinology 143:304-312
8. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
9. Lane AH, Donahoe PK 1998 New insights into Mullerian inhibiting substance and its mechanism of action. J Endocrinol 158:1-6
10. Teixeira JT, Maheswaran S and Donahoe PK 2001 Mullerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 22:657-674
11. Josso N, di Clemente N, Gouedard L 2001 Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol 179:25-32
12. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT 1996 Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576
13. Long WQ, Ranchin V, Pautier P, Belville C, Denizot P, Cailla H, Lhomme C, Picard JY, Bidart JM, Rey R 2000 Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85:540-544
14. Cook CL, Siow Y, Taylor S, Fallat ME 2000 Serum Mullerian inhibiting substance levels during normal menstrual cycles. Fertil Steril 73:859-861
15. Josso N, Legeai L, Forest MG, Chaussain JL, Brauner R 1990 An enzyme linked immunoassay for anti-Mullerian hormone: a new tool for the evaluation of testicular function in infants and children. J Clin Endocrinol Metab 70:23-27
16. Hudson PL, Dougas I, Donahoe PK, Care RL, Epstein J, Pepinsky RB, MacLaughlin DT 1990 An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70:16-22
17. Baker ML, Metcalfe SA, Hutson JM 1990 Serum levels of Mullerian inhibiting substance in boys from birth to 18 years, as determined by enzyme immunoassay. J Clin Endocrinol Metab 70:11-15
18. Schwindt B, Doyle LW, Hutson JM 1997 Serum levels of Mullerian inhibiting substance in preterm and term male neonates. J Urol 158:610-612
19. Rey RA, Belville C, Nihoul-Fekete C, Michel-Calemard L, Forest MG, Lahlou N, Jaubert F, Mowszowicz I, David M, Saka N, Bouvattier C, Bertrand AM, Lecointre C, Soskin S, Cabrol S, Crosnier H, Leger J, Lortat-Jacob S, Nicolino M, Rabl W, Toledo SP, Bas F, Gompel A, Czemichow P, Josso N 1999 Evaluation of gonadal function in 107 intersex patients by means of serum anti-mullerian hormone measurement. J Clin Endocrinol Metab 84:627-631
20. Josso N, Boussin L, Knebelmann B, Nihoul-Fekete C, Picard JY 1991 Anti-Mullerian hormone and intersex states. Trends Endocrinol Metab 2:227-233
21. Josso N 1995 Paediatric applications of anti-Mullerian hormone research. 1992 Andrea Prader Lecture. Horm Res 43:243-248
22. Lee MM, Donahoe PK, Silverman BL, Hasegawa T, Hasegawa Y, Gustafson ML, Chang YC, MacLaughlin DT 1997 Measurement of serum Mullerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med 336:1480-1486
23. Lane AH, Lee MM 2001 Mullerian inhibiting substance: a sensitive marker of gonadal function. Curr Opin Endocrinol Diabetes 8:296-300
24. Misra M, McLaughlin D, Donahoe P, Lee MM 2002 Measurement of MIS facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 87:3598-3602
25. Durlinger ALL, Kramer P, Karles B, deJong FH, Uilenbroek JTJ, Grootegoed JA, Themmen AP 1999 Control of primordial follicle recruitment by anti-mullerian hormone in the mouse ovary. Endocrinology 140:5789-5796
26. Cook CL, Siow Y, Brenner AG, Fallat ME 2002 Relationship between serum Mullerian inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 77:141-146
27. Sayegh RA, DeLellis R, Alroy J, Lechan R, Ball HG 1999 Masculinizing granulosa cell tumor of the ovary in a postmenopausal woman. A case report J Reprod Med 44:821-825
28. Betta P, Bellingeri D 1985 Androgenic juverule granulosa cell tumour Case Report. Eur J Gynaecol Oncol 6:71-74
29. Lane AH, Lee MM, Fuller Jr AF, Kehas DJ, Donahoe PK, MacLaughlin DT 1999 Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol Oncol 73:51-55
30. Rey R, Sabourin JC, Venara M, Long WQ, Jaubert F, Zeller WP, Duvillard P, Chemes H, Bidart JM 2000 Anti-Mullerian hormone is a specific marker of Sertoli-and granulosa-cell origin in gonadal tumors. Hum Pathol 31:1202-1208
31. Fleiss JL 1981 Statistical methods for rates and proportions. 2nd ed. New York: John Wiley and Sons; 4-8
32. Johnson NL, Kotz S, Kemp AW 1992 Univariate discrete distributions. 2nd ed. New York: John Wiley and Sons; 124-130
33. Donahoe PK, Crawford JD, Hendren WH 1978 True hermaphroditism: a clinical description and a proposed function for the long arm of the Y chromosome. J Pediatr Surg 13:293-301
34. Rutgers JL, Scully RE 1987 Pathology of the testis in intersex syndromes. Semin Diagn Pathol 4:275-291
35. Gustafson ML, Lee MM, Asmundson L, MacLaughlin DT, Donahoe PK 1993 Mullerian inhibiting substance in the diagnosis and management of intersex and gonadal abnormalities. J Pediatr Surg 28:439-444
36. Guerrier D, Tran D, Vanderwinden JM, Hideux S, Van Outryve L, Legeai L, Bouchard M, Van Vliet G, De Laet MH, Picard JY 1989 The persistent Mullerian duct syndrome: a molecular approach. J Clin Endocrinol Metab 68:46-52
37. Imbeaud S, Carre-Eusebe D, Rey R, Belville C, Josso N, Picard JY 1994 Molecular genetics of the persistent Mullerian duct syndrome: a study of 19 families. Hum Mol Genet 3:125-131
38. Belville C, Josso N, Picard JY 1999 Persistence of Mullerian derivatives in males. Am J Med Genet 89:218-223
39. Lustig RH, Conte FA, Kogan BA, Grumbach MM 1987 The ontogeny of gonadotropin secretion in congenital anorchism: sexual dimorphism versus syndrome of gonadal dysgenesis and diagnostic considerations. J Urol 138:587-591
40. Lee PA 2000 Appropriate use and interpretation of human chorionic gonadotropin stimulation in prepubertal male patients. Endocr Prac 6:112-114
41. Krob G, Braun A, Kuhnle U 1994 True hermaphroditism: geographical distribution, clinical findings, chromosomes and gonadal histology. Eur J Pediatr 153:2-10
42. Kadandale JS, Wachtel SS, Tunca Y, Wilroy Jr RS, Martens PR, Tharapel AT 2000 localization of SRY by primed in situ labeling in XX and XY sex reversal. Am J Med Genet 95:71-74